Journalism of Courage
Advertisement
Prabha Raghavan
Authors you can follow
More From Prabha Raghavan - Page 11
‘We will take about three months to finish phase I and II clinical trials’: Zydus Cadila’s Pankaj R PatelSubscriber Only
July 04, 2020 10:33 IST
Coronavirus, Covid-19 Zydus Cadila ZyCov-D Vaccine: In an interview with The Indian Express, Patel discusses how the firm developed its vaccine candidate, the timeline it has in mind for its trials and other vaccine candidates it is considering.
Sun, Jul 05, 2020
Zydus plans to finish first two phases of vaccine trials in 3 monthsSubscriber Only
July 04, 2020 01:49 IST
The trials will begin this month in over 1,000 patients across multiple sites, hotting up India’s race for a vaccine against the contagious virus that had caused a nationwide lockdown.
Sat, Jul 04, 2020
ICMR wants to launch Covaxin by August 15: What you need to know about India’s vaccineSubscriber Only
July 03, 2020 14:17 IST
ICMR has targeted August 15 launch for Covid-19 vaccine. How much remains in the trial process? How have other vaccine candidates progressed?
Sun, Jul 26, 2020
Explained: Why China factor has led to an increase in price of Heparin; will other drugs follow?Subscriber Only
July 02, 2020 17:26 IST
The heparin sodium API for the injections made in India majorly comes from China, according to pharma companies. Some industry bodies say there aren't many alternative manufacturers for the API, especially in India.
Thu, Jul 02, 2020
Rising costs of raw materials from China: NPPA to allow pharma cos to raise heparin price by 50%Subscriber Only
July 02, 2020 03:31 IST
The price hike also comes as heparin was among several drugs flagged by the health ministry as essential medicines that needed to remain in stock while the country battled the ongoing Covid-19 pandemic.
Thu, Jul 02, 2020
Explained: What is Covaxin, India’s Covid-19 vaccine candidate; how long before approval?Subscriber Only
June 30, 2020 17:03 IST
India's Covid-19 vaccine candidate Covaxin: How does Covaxin compare to other vaccine candidates around the world? Where does it figure in the global race for a Covid-19 vaccine?
Thu, Jul 02, 2020
Ban on PPE export lifted, limit set at 5 million a monthSubscriber Only
June 29, 2020 14:26 IST
Capping the monthly quota at 50 Lakh units, the Government on Monday permitted shipments of Covid-19 PPE medical coveralls after banning this product for export earlier.
Tue, Jun 30, 2020
Now, Indian exporters complain shipments stuck at China portsSubscriber Only
June 27, 2020 04:34 IST
In a recent note to the Ministry of Commerce and Industry, the Federation of Indian Export Organisations (FIEO) has said that Hong Kong and Chinese Customs were holding back export consignments from India over the last few days.
Sat, Jun 27, 2020
Explained: Will banning Chinese imports hurt India’s exports?Subscriber Only
June 26, 2020 21:22 IST
Across sectors from pharmaceuticals to telecommunications and automobiles, industry associations have been speaking up against a complete boycott of Chinese imports.
Sun, Jun 28, 2020
Trade bodies say need time to stop reliance on imports from ChinaSubscriber Only
June 26, 2020 05:25 IST
Federation of Indian Export Organisation’s (FIEO’s) President, Sharad Kumar Saraf, and Director General, Ajay Sahai, hinted on Thursday that a “blanket ban” may not be feasible. The India Cellular and Electronics Association and the Automotive Component Manufacturers
Fri, Jun 26, 2020
Explained: Why shipments from China are stuck at Indian portsSubscriber Only
June 25, 2020 18:55 IST
It is learnt that over the last fortnight, as tensions on the Ladakh border grew, Customs authorities have indicated to importers that there will be delays in clearing Chinese shipments, but have not cited any reasons.
Sat, Jun 27, 2020
E-comm firms told: Let buyers know country of origin of goodsSubscriber Only
June 25, 2020 04:19 IST
Experts say such a requirement does not have a precedent, may not be easy to roll out and may require more brainstorming, especially for products, such as cellphones and laptops, that may have inputs from several countries.
Thu, Jun 25, 2020
Why does the govt want ‘country of origin’ flagged on procurement portal? How will you be impacted?Subscriber Only
June 24, 2020 15:55 IST
Decision comes after the Aatmanirbhar Bharat push and the tensions with China, which is a source of many commonly used goods. There is also a move to extend this requirement to private e-commerce platforms.
Thu, Jun 25, 2020
PM-JAY saw 57% fall in surgeries, 46% in medical care during lockdownSubscriber Only
June 22, 2020 01:09 IST
Overall, there was a 57% decline in surgical procedures — from 62,630 claims per week on an average pre-lockdown to 27,167 during the lockdown. Medical cases recorded a 46% fall — 65,341 average claims per week before the lockdown to 35,108.
Mon, Jun 22, 2020
COVID-19: Hetero, Cipla get nod to manufacture, market antiviral drug remdesivirSubscriber Only
June 21, 2020 10:46 IST
Cipla and Hetero Labs have already entered into non-exclusive licensing agreements with US pharma giant Gilead Sciences, which is the patent holder of the drug remdesivir.
Sun, Jun 21, 2020
Stopping China imports may hurt India’s edge, exports: telcos, pharma companiesSubscriber Only
June 20, 2020 01:08 IST
China accounts for around 14 per cent of India’s imports, with major items in the import basket being components for smartphones and automobile, telecom equipment, plastic and metallic goods, APIs, and other chemicals.
Sat, Jun 20, 2020
Glenmark’s antiviral FabiFlu gets CDSCO emergency use approval, with ridersSubscriber Only
June 20, 2020 01:03 IST
The approval has been granted on the condition that the drug be administered only with informed consent.
Sat, Jun 20, 2020
Dexamethasone, under spotlight for ‘improving survival’, may see rising demandSubscriber Only
June 18, 2020 03:04 IST
The “first drug to be shown to improve survival”, dexamethasone reduces death by up to a third in COVID-19 patients on ventilator support, and by a fifth in patients receiving only oxygen, researchers leading the trial had announced.
Thu, Jun 18, 2020No supply of remdesivir yet, drug regulator says won’t allow illegal entry from BangladeshSubscriber Only
June 17, 2020 01:42 IST
Demand for remdesivir, still an investigational drug for use in treating coronavirus, has been on the rise after Drug Controller General of India Dr V G Somani granted emergency use approval for its supply to Gilead Sciences, the firm that developed it, on June 1.
Wed, Jun 17, 2020
Gilead’s remdesivir now part of India’s Covid treatment protocol, but licences for 5 firms are stuck in red tapeSubscriber Only
June 14, 2020 04:30 IST
It is unclear though how many firms with voluntary licences from Gilead have received the drug regulator’s go-ahead to manufacture and supply remdesivir in India.
Sun, Jun 14, 2020
Glenmark Pharma, Sun Pharma, Lupin, Wockhardt, Aurobindo Pharma named in US anti-trust lawsuitSubscriber Only
June 12, 2020 03:08 IST
The topical drugs at the center of the complaint include creams, gels, lotions, ointments, shampoos and solutions used to treat a variety of skin conditions, pain, and allergies.
Fri, Jun 12, 2020
Maharashtra: State govt puts on hold decision to buy drug from Bangladeshi firmSubscriber Only
June 10, 2020 06:01 IST
Maharashtra, with over 83,000 cases, accounts for 33 per cent of India’s Covid-19 burden. The state has used Remdesivir, so far available on donation, on selected severely ill patients, but even in them a cocktail of other drugs have been used to treat Covid-19.
Wed, Jun 10, 2020
Maharashtra plans to buy 10,000 vials of Remdesivir: TopeSubscriber Only
June 07, 2020 03:40 IST
An anti-viral drug, Remdesivir is being used on moderately ill to severely ill patients to stop the spread of the virus in the body. It was manufactured in 2014 to treat Ebola and has since been used to treat patients of SARS and MERS.
Sun, Jun 07, 2020
Dabur chairman Amit Burman: ‘Availability of manpower has become a serious issue’Subscriber Only
June 05, 2020 04:52 IST
Dabur chairman Amit Burman speaks to The Indian Express on how the company has been overcoming challenges posed by the Covid-19 lockdown and what the government can do to support the industry during this time.
Fri, Jun 05, 2020
Private hospitals’ body, Ficci propose caps on COVID-19 treatment costSubscriber Only
June 05, 2020 01:23 IST
While these rates are not binding, the Association of Healthcare Providers of India (AHPI) and Federation of Indian Chambers of Commerce and Industry (FICCI) are submitting their suggestions to the central and state governments.
Fri, Jun 05, 2020Journalism of Courage
Install the Express App for
a better experience
a better experience
Featured
Trending Topics
News
Multimedia
Follow Us